MSH Capital Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.06M | Buy |
43,632
+9,047
| +26% | +$219K | 0.3% | 91 |
|
|
2025
Q1 | $876K | Buy |
34,585
+485
| +1% | +$12.3K | 0.27% | 100 |
|
|
2024
Q4 | $905K | Sell |
34,100
-32,398
| -49% | -$860K | 0.28% | 94 |
|
|
2024
Q3 | $1.92M | Sell |
66,498
-306
| -0.5% | -$8.86K | 0.59% | 54 |
|
|
2024
Q2 | $1.87M | Buy |
66,804
+1,921
| +3% | +$53.7K | 0.62% | 51 |
|
|
2024
Q1 | $1.8M | Sell |
64,883
-423
| -0.6% | -$11.7K | 0.63% | 52 |
|
|
2023
Q4 | $1.88M | Sell |
65,306
-4,535
| -6% | -$131K | 0.7% | 46 |
|
|
2023
Q3 | $2.32M | Buy |
69,841
+5,704
| +9% | +$189K | 0.91% | 29 |
|
|
2023
Q2 | $2.35M | Buy |
64,137
+8,326
| +15% | +$305K | 0.86% | 35 |
|
|
2023
Q1 | $2.28M | Buy |
55,811
+582
| +1% | +$23.7K | 0.97% | 26 |
|
|
2022
Q4 | $2.83M | Buy |
55,229
+1,006
| +2% | +$51.5K | 1.28% | 17 |
|
|
2022
Q3 | $2.37M | Sell |
54,223
-30
| -0.1% | -$1.31K | 1.17% | 18 |
|
|
2022
Q2 | $2.84M | Buy |
54,253
+626
| +1% | +$32.8K | 1.32% | 15 |
|
|
2022
Q1 | $2.78M | Buy |
53,627
+3,595
| +7% | +$186K | 1.15% | 19 |
|
|
2021
Q4 | $2.95M | Buy |
+50,032
| New | +$2.95M | 1.32% | 16 |
|